Granulocyte colony-stimulating factor worsens the outcome of experimental Klebsiella pneumoniae pneumonia through direct interaction with the bacteria

Blood

Volumn 91, Issue 7, 1998, Pages 2525-2535

  Held, Thomas K ^a   Mielke, Martin E A ^b   Chedid, Marcio ^b   Unger, Matthias ^b   Trautmann, Matthias ^b   Huhn, Dieter ^b   Cross, Alan S ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL PNEUMONIA; BACTERIAL VIRULENCE; CONTROLLED STUDY; HOST RESISTANCE; IMMUNOMODULATION; IMMUNOREACTIVITY; KLEBSIELLA PNEUMONIAE; LEUKOCYTE ACTIVATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LUNG; MICE; MICE, INBRED BALB C; PNEUMONIA, BACTERIAL; POLYSACCHARIDES, BACTERIAL; SURVIVAL ANALYSIS;

EID: 0032055111     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Lieschke GJ, Burgess AW: Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 327:99, 1992
2. Vose JM, Armitage JO: Clinical applications of hematopoietic growth factors. J Clin Oncol 13:1023, 1995
3. Nelson S, Summer W, Bagby G, Nakamura C, Stewart L, Lipscomb G, Andresen J: Granulocyte colony-stimulating factor enhances pulmonary host defences in normal and ethanol-treated rats. J Infect Dis 164:901, 1991
4. Lister PD, Gentry MJ, Preheim LC: Granulocyte colony-stimulating factor protects control rats but not ethanol-fed rats from fatal pneumococcal pneumonia. J Infect Dis 168:922, 1993
5. Hebert JC, O'Reilly M, Gamelli RL: Protective effect of recombinant human granulocyte colony-stimulating factor against pneumococcal infections in splenectomized mice. Arch Surg 125:1075, 1990
6. Abraham E, Stevens P: Effects of granulocyte colony-stimulating factor in modifying mortality from Pseudomonas aeruginosa pneumonia after hemorrhage. Crit Care Med 20:1127, 1992
7. Matsumoto M, Matsubara S, Matsuno T, Tamura M, Hattori K, Nomura H, Ono M, Yokota T: Protective effect of human granulocyte colony-stimulating factor on microbial infection in neutropenic mice. Infect Immun 55:2715, 1987
8. Matsumoto M, Matsubara S, Yokota T: Effect of combination therapy with recombinant human granulocyte colony-stimulating factor (rG-CSF) and antibiotics in neutropenic mice unresponsive to antibiotics alone. J Antimicrob Chemother 29:447, 1991
9. Bartlett JG, O'Keefe P, Tally FP, Louie TJ, Gorbach SL: Bacteriology of hospital-acquired pneumonia. Arch Intern Med 146:868, 1986
10. Jarvis WR, Munn VP, Highsmith AK, Culver DH, Hughes JM: The epidemiology of nosocomial infections caused by Klebsiella pneumoniae. Infect Control 6:68, 1985
11. McGowan JE Jr: Changing etiology of nosocomial bacteremia and fungemia and other hospital-acquired infections. Rev Infect Dis 7:S357, 1985 (Suppl 3)
12. Carpenter JL: Klebsiella pulmonary infections: Occurence at one medical center and review. Rev Infect Dis 12:672, 1990
13. Jay SJ: Nosocomial pneumonia. Nosocomial Infect 74:221, 1983
14. Hupkova M, Blahova J, Babalova M, Krcmery V, Kralikova K: Transferable resistance to cefotaxime in nosocomial Klebsiella pneumoniae and Escherichia coli strains due to their production of extended-spectrum beta-lactamase in Slovakia. J Chemother 7:16, 1995
15. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ: Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 119:353, 1993
16. MacKenzie FM, Forbes KJ, Dorai-John T, Amyes SGB, Gould IM: Emergence of a carbapenem-resistant Klebsiella pneumoniae. Lancet 350:783, 1997
17. Trautmann M, Cryz SJ Jr, Sadoff JC, Cross AS: A murine monoclonal antibody against Klebsiella capsular polysaccharide is opsonic in vitro and protects against experimental Klebsiella pneumoniae infection. Microb Pathog 5:177, 1988
18. Held TK, Trautmann M, Mielke MEA, Neudeck H, Cryz SJ Jr, Cross AS: Monoclonal antibody against Klebsiella capsular polysaccharide reduces severity and hematogenic spread of experimental Klebsiella pneumoniae pneumonia. Infect Immun 60:1771, 1992
19. Held TK, Adamczik C, Trautmann M, Cross AS: Effects of MICs and sub-MICs of antibiotics on production of capsular polysaccharide of Klebsiella pneumoniae. Antimicrob Agents Chemother 39:1093, 1995
20. Trautmann M, Vogt K, Hammack C, Cross AS: A murine monoclonal antibody defines a unique epitope shared by Klebsiella lipopolysaccharides. Infect Immun 62:1282, 1994
21. Uchida T, Yamagiwa A: Kinetics of rG-CSF-induced neutrophilia in mice. Exp Hematol 20:152, 1992
22. Sidberry H, Kaufman B, Wright DC, Sadoff J: Immunochemical analysis by monoclonal antibodies of bacterial lipopolysaccharides after transfer to nitrocellulose. J Immunol Methods 76:299, 1985
23. Hulme EC: Receptor-binding studies, a brief outline, in Hulme EC (ed): Receptor Biochemistry, A Practical Approach. Oxford, UK, IRL Press at Oxford University Press, 1990, p 303
24. Trautmann M, Ghandchi A, Held T, Cryz SJ Jr, Cross AS: An enzyme-linked immunosorbent assay for the detection of soluble Klebsiella pneumoniae capsular polysaccharide. J Microbiol Methods 13:305, 1991
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193:265, 1951
26. Cross AS, Lowell GH, Palmblad J, Sadoff JC, Young L, Berger M: Mechanism of priming of human neutrophils by a soluble lymphoblastoid cell factor. J Immunol 135:2074, 1985
27. Petros WP: Pharmacokinetics and administration of colony-stimulating factors. Pharmacotherapy 12(2 Pt 2):32S, 1992
28. Domenico P, Salo RJ, Cross AS, Cunha BA: Polysaccharide capsule-mediated resistance to opsonophagocytosis in Klebsiella pneumoniae. Infect Immun 62:4495, 1994
29. Porat R, Clark BD, Wolff SM, Dinarello CA: Enhancement of growth of virulent strains of Escherichia coli by interleukin-1. Science 254:430, 1991
30. Denis M, Campbell D, Gregg EO: Interleukin-2 and granulocyte-macrophage colony-stimulating factor stimulate growth of a virulent strain of Escherichia coli. Infect Immun 59:1853, 1991
31. Luo G, Niesel DW, Shaban RA, Grimm EA, Klimpel GR: Tumor necrosis factor alpha binding to bacteria: Evidence for a high-affinity receptor and alteration of bacterial virulence properties. Infect Immun 61:830, 1993
32. Denis M: Interleukin-6 is used as a growth factor by virulent Mycobacterium avium: Presence of specific receptors. Cell Immunol 141:182, 1992
33. Smith WS, Sumnicht GE, Sharpe RW, Samuelson D, Millard FE: Granulocyte colony-stimulating factor versus placebo in addition to penicillin G in a randomized blinded study of gram-negative pneumonia sepsis: Analysis of survival and multisystem organ failure. Blood 86:1301, 1995
34. DeMarsh PL, Wells GI, Lewandowski TF, Bhatnagar PK, Ostovic EJ: Effect of SK&F 107647, a novel hemoregulatory peptide, M-CSF or G-CSF in the rat fibrin-thrombin clot model of gram-negative and gram-positive sepsis. 96th General Meeting of the American Society for Microbiology, New Orleans, LA, May 19-23, 1996, p 266 (abstr E-1)
35. von Reyn CF, Arbeit RD, Tosteson ANA, Ristola MA, Barber TW, Waddell R, Sox CH, Brindle RJ, Gilks CF, Ranki A, Bartholomew C, Edwards J, Falkinham JO III, O'Connor GT, The International MAC Study Group: The international epidemiology of disseminated Mycobacterium avium complex infection in AIDS. AIDS 10:1025, 1996
36. Roilides E, Walsh TJ, Pizzo PA, Rubin M: Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis 163:579, 1991
37. Domenico P, Johanson WG Jr, Straus DC: Lobar pneumonia in rats produced by clinical isolates of Klebsiella pneumoniae. Infect Immun 37:327, 1982
38. Ehrenworth L, Baer H: The pathogenicity of Klebsiella pneumoniae for mice: The relationship to the quantity and rate of production of type-specific capsular polysaccharide. J Bacteriol 72:713, 1956
39. Kabha K, Nissimov L, Athamna A, Keisari Y, Parolis H, Parolis LA, Grue RM, Schlepper-Schafer J, Ezekowitz AR, Ohman DE: Relationships among capsular structure, phagocytosis, and mouse virulence in Klebsiella pneumoniae. Infect Immun 63:847, 1995
40. Simoons-Smit AM, Verweij-van Vught AM, Maclaren DM: The role of K antigens as virulence factors in Klebsiella. J Med Microbiol 21:133, 1986
41. Dinarello CA: Role of interleukin-1 in infectious diseases. Immunol Rev 127:119, 1992
42. Yasuda H, Ajiki Y, Shimozato T, Kasahara M, Kawada H, Iwata M, Shimizu K: Therapeutic efficacy of granulocyte colony-stimulating factor alone and in combination with antibiotics against Pseudomonas aeruginosa infections in mice. Infect Immun 58:2502, 1990
43. Lang CH, Bagby GJ, Dobrescu C, Nelson S, Spitzer JJ: Effect of granulocyte colony-stimulating factor on sepsis-induced changes in neutrophil accumulation and organ glucose uptake. J Infect Dis 166:336, 1992
44. Lorenz W, Reimund K-P, Weitzel F, Celik I, Kurnatowski M, Schneider C, Mannheim W, Heiske A, Neumann K, Sitter H, Rothmund M: Granulocyte colony-stimulating factor prophylaxis before operation protects against lethal consequences of postoperative peritonitis. Surgery 116:925, 1994
45. Balazovich KJ, Almeida HI, Boxer LA: Recombinant human G-CSF and GM-CSF prime human neutrophils for Superoxide production through different signal transduction mechanisms. J Lab Clin Med 118:576, 1991
46. Roilides E, Uhlig K, Venzon D, Pizzo PA, Walsh TJ: Neutrophil oxidative burst in response to Blastoconidia and Pseudohyphae of Candida albicans: Augmentation by granulocyte colony-stimulating factor and interferon-γ. J Infect Dis 166:668, 1992
47. Nathan CF: Respiratory burst in adherent human neutrophils: Triggering by colony-stimulating factors CSF-GM and CSF-G. Blood 73:301, 1989
48. Yuo A, Kitagawa S, Ohsaka A, Ohta M, Miyazono K, Okabe T, Urabe A, Saito M, Takaku F: Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: Potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence. Blood 73:2144, 1989
49. Dale DC: Potential role of colony-stimulating factors in the prevention and treatment of infectious diseases. Clin Infect Dis 18:S180, 1994 (Suppl 2)
50. Nelson S: Role of granulocyte colony-stimulating factor in the immune response to acute bacterial infection in the nonneutropenic host: An overview. Clin Infect Dis 18:S197, 1994 (Suppl 2)
51. Glauser MP: The evolving role of colony-stimulating factors and other biotherapies in infection. J Infect Dis 18:S169, 1994 (Suppl 2)
52. Weiss M, Gross-Weege W, Schneider M, Neidhardt H, Liebert S, Mirow N, Wernet P: Enhancement of neutrophil function by in vivo filgrastim treatment for prophylaxis of sepsis in surgical intensive care patients. J Crit Care 10:21, 1995